Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950142-21-001962
Filing Date
2021-06-11
Accepted
2021-06-11 16:59:50
Documents
1
Group Members
GAP (BERMUDA) LTDGENERAL ATLANTIC (LUX) S.A R.L.GENERAL ATLANTIC COOPERATIEF U.A.GENERAL ATLANTIC COOPERATIEF, L.P.GENERAL ATLANTIC GENPAR (BERMUDA), L.P.GENERAL ATLANTIC GENPAR (LUX) SCSPGENERAL ATLANTIC PARTNERS (BERMUDA) EU, L.P.GENERAL ATLANTIC PARTNE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh210159595_13d-centessa.htm SC 13D 277383
  Complete submission text file 0000950142-21-001962.txt   279547
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Subject) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92588 | Film No.: 211012053
SIC: 2834 Pharmaceutical Preparations

Mailing Address RAAMPLEIN 1 AMSTERDAM P7 1016 XK
Business Address RAAMPLEIN 1 AMSTERDAM P7 1016 XK 212-715-4000
General Atlantic Cooperatief U.A. (Filed by) CIK: 0001859266 (see all company filings)

EIN.: 980544370 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D